We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$314M
2
DT icon
Dynatrace
DT
+$312M
3
CSGP icon
CoStar Group
CSGP
+$301M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$249M
5
CLVT icon
Clarivate
CLVT
+$237M

Top Sells

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$411M
2
RTX icon
RTX Corp
RTX
+$335M
3
CERN
Cerner Corp
CERN
+$312M
4
AVGO icon
Broadcom
AVGO
+$257M
5
PLAN
Anaplan, Inc.
PLAN
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 30.97%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
51
Bruker
BRKR
$9.07B
$88.3M 0.48%
1,406,800
+345,000
+32% +$21.2M
CYTK icon
52
Cytokinetics
CYTK
$10.7B
$88.2M 0.48%
2,245,038
+362,439
+19% +$14.6M
TPTX
53
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$87.3M 0.47%
+1,160,000
New +$51.6M
SWCH
54
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$78.1M 0.42%
+2,330,000
New +$75.3M
ABBV icon
55
AbbVie
ABBV
$468B
$77.4M 0.42%
505,515
-639,152
-56% -$97.7M
INSP icon
56
Inspire Medical Systems
INSP
$1.8B
$75.4M 0.41%
413,000
+129,500
+46% +$25.8M
ENTA icon
57
Enanta Pharmaceuticals
ENTA
$392M
$73.3M 0.4%
1,550,000
– –
SIMO icon
58
Silicon Motion
SIMO
$8.76B
$65M 0.35%
+776,510
New +$65.4M
RVMD icon
59
Revolution Medicines
RVMD
$44.9B
$63.3M 0.34%
3,250,000
– –
PCG icon
60
PG&E
PCG
$38.8B
$62.9M 0.34%
6,305,142
– –
BPMC
61
DELISTED
Blueprint Medicines
BPMC
$61.2M 0.33%
1,211,987
-145,000
-11% -$8.49M
BIIB icon
62
Biogen
BIIB
$32B
$56.8M 0.31%
278,499
+80,700
+41% +$16.5M
LHCG
63
DELISTED
LHC Group LLC
LHCG
$45.2M 0.24%
+290,000
New +$47.8M
CTLT
64
DELISTED
CATALENT, INC.
CTLT
$45M 0.24%
419,755
-296,800
-41% -$30.2M
TSEM icon
65
Tower Semiconductor
TSEM
$25.2B
$43.9M 0.24%
+950,000
New +$45.2M
SAIL
66
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$41M 0.22%
+653,534
New +$40.3M
AMRS
67
DELISTED
Amyris Inc.
AMRS
$39.2M 0.21%
21,209,882
+4,278,455
+25% +$12.6M
IOVA icon
68
Iovance Biotherapeutics
IOVA
$3.76B
$35.1M 0.19%
3,176,773
-2,998,584
-49% -$39.3M
IMGO
69
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$33.1M 0.18%
2,471,313
– –
ZEN
70
DELISTED
ZENDESK INC
ZEN
$32.6M 0.18%
440,000
-190,000
-30% -$18.7M
BRMK
71
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$32.5M 0.18%
4,850,000
– –
VG
72
DELISTED
Vonage Holdings Corporation
VG
$32.5M 0.18%
1,727,000
+735,000
+74% +$14.1M
AGIO icon
73
Agios Pharmaceuticals
AGIO
$1.98B
$29.6M 0.16%
1,333,012
– –
GATE
74
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$29.3M 0.16%
2,970,000
– –
PTGX icon
75
Protagonist Therapeutics
PTGX
$9.99B
$29.3M 0.16%
3,700,608
+2,566,151
+226% +$31M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2022 Portfolio in Review

As of Q2 2022, Thomas Steyer held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Twitter, Inc. worth $274M.

  • Thomas Steyer's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Thomas Steyer added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Thomas Steyer's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Thomas Steyer fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Thomas Steyer's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Thomas Steyer opened 22 new positions and closed 30 in Q2 2022.
  • Thomas Steyer's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.